Your Recent Quotes: 0 | 0

Medicis Pharmaceutical Corporation

Related Information and Financials
Price Glossary Definition
19.89 -0.23
-1.14%
9/05/08 4:01
Open
20.07
Prev Close
20.12
Volume
900,168
52 Wk. Range
17.72-32.18
Year-to-Date Performance Glossary Definition
DOWN  -23.41%
Latest Dividend
Dividend
0.04
Yield
0.80
Ex-Date
06/27/2008
Price/Earnings Comparisons Glossary Definition
 
13.53
 
15.80
 
19.80
MRX
Sect. Av.
S&P 500
Market Cap
1,128,061,300
Outstanding Shares
56,397,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy MRX Rating Report
Target Price (1Yr)
High
39.00
Revenue
535,500,000

Annual Dividend
Rate
0.16
Yield
0.80
Growth
12 Month
3 Year
CAGR
Revenue
33.00
0.53
0.15
Net Income
1.43
0.34
EPS
1.44
0.34

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
-17.67
-35.90
-42.05
Earnings Per Share($)

06/2004
 
 
 
0.00
12/2006
 
 
 
-1.39
12/2007
 
 
 
1.34

Earnings
EBITDA
127,857,000
Revenue
464,651,000
Outside Analyst Rating History

9/8/08
4
Buy
9/8/08
5
Hold
9/8/08
1
Sell

Jim Cramer Portfolio
Find out now if MRX is in Jim's personal portfolio at Action Alerts PLUS.
Compare This Stock
Latest Headlines
People are struggling to pay their home and car loans but refuse to sacrifice plastic surgery. The business is booming as people find ways to finance their beauty makeovers.

02:50PM 08/07/08

Watch Video
Video
Maxygen climbs on news of a deal with Bayer HealthCare.

4:16PM 07/02/08

In this June 20 'Mad Money' clip Jim Cramer and Jonah Shacknai discuss Medicis Pharmaceutical's growth and stock.

08:06PM 06/22/08

Watch Video
Video
Shares rise 15.9% after the company completed the initial portion of the Goliad ISR Uranium Project.

4:09PM 06/17/08

Elan climbs on drug study data.

3:56PM 06/17/08

Alnylam climbs on an earnigns beat.

4:57PM 05/09/08

Earnings lift Medicis and Nektar, but slam PharmaNet and Osiris.

4:25PM 02/28/08

Allergan's holding up nicely despite recession talk; is the Botox and breast implant maker the best play for an economic downturn?

03:48PM 02/20/08

Watch Video
Video
The agency is primarily looking at the off-label use of the wrinkle reducer in children.

6:06PM 02/08/08

Labopharm climbs on drug study results.

3:30PM 02/08/08

Understanding the Market

Our Experts' Take at RealMoney
Kendle is a research contract firm that is interesting here, when so many stocks aren't.

2:55PM 09/05/08

The financials are fine -- we just need to be patient.

2:39PM 09/05/08

More Experts' Takes


Premium Stock Ideas
Is Cramer trading MRX in his Action Alerts Plus Portfolio?